Indivior plunges after losing opioid addiction patent case
LONDON (Reuters) - Britain's Indivior is set to face cheap competition to its opioid addiction treatment Suboxone Film after losing a patent protection case, sending its shares more than 20 percent lower on Friday.
from Reuters: Health News http://reut.rs/2pxU58P
http://bit.ly/2zwRqiM
March 23, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on March 23, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.